Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neuronetics Inc (NQ: STIM )

1.830 +0.030 (+1.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 72,435
Open 1.780
Bid (Size) 1.750 (1)
Ask (Size) 2.400 (46)
Prev. Close 1.800
Today's Range 1.780 - 1.880
52wk Range 1.030 - 6.952
Shares Outstanding 28,933,132
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
Technological advances reduce time and increase efficiency for MDD treatment 
From Neuronetics
Via GlobeNewswire
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
New updates designed to advance practice efficiency and patient outcomes 
From Neuronetics
Via GlobeNewswire

Performance

YTD
-72.27%
-72.27%
1 Month
+30.71%
+30.71%
3 Month
+19.61%
+19.61%
6 Month
-24.38%
-24.38%
1 Year
-70.67%
-70.67%

More News

Read More
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
From Neuronetics
Via GlobeNewswire
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
From Neuronetics
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
From Neuronetics
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
From Neuronetics
Via GlobeNewswire
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
From Neuronetics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
From Neuronetics
Via GlobeNewswire
Neuronetics' NeuroStar Gets Regulatory Clearance In South Korea
Via Benzinga
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
From Neuronetics
Via GlobeNewswire
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
From Neuronetics
Via GlobeNewswire
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
From Neuronetics
Via GlobeNewswire
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
From Neuronetics
Via GlobeNewswire
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
From Neuronetics
Via GlobeNewswire
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Earnings Scheduled For May 9, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.